Literature DB >> 476575

Relationship between proliferative activity and estrogen receptors in breast cancer.

R Silverstrini, M G Daidone, G Di Fronzo.   

Abstract

The proliferative activity of breast cancer has been analyzed in relation to the hormonal characteristics of the host and of the tumor for 199 patients. The analyses of labeling index frequency distributions of estrogen receptor positive (ER+) and negative (ER-) cancers from premenopausal and postmenopausal patients have allowed us to identify three different kinetic groups. A first group, with a very low proliferative activity, includes ER+ cancers from postmenopausal patients; a second group, with an intermediate proliferative activity, includes ER+ cancers from premenopausal and ER- cancers from postmenopausal patients; and a third group, with a very high proliferative activity, includes ER- cancers from premenopausal patients. Generally, the amount of estrogen receptors in ER+ cancers is inversely correlated with the proliferative activity. Lower levels of ER in premenopausal in comparison to postmenopausal patients were found in low proliferative activity tumors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476575     DOI: 10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Influence of fetal bovine serum and hormones on primary vs. long-term cultures of human breast cancers.

Authors:  Y de Launoit; P Gasperin; O Pauwels; D Larsimont; S Gras; R Kiss
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

2.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

Review 3.  Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 5.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

6.  Significance of the Tritiated Thymidine Labeling Index in breast cancers.

Authors:  K Araki; M Kimura; K Sakamoto; R Nishimura; M Akagi
Journal:  Jpn J Surg       Date:  1985-03

7.  Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.

Authors:  M A Fanelli; L M Vargas-Roig; F E Gago; O Tello; R Lucero De Angelis; D R Ciocca
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Cell kinetics and polyamine enzymes in the intestinal mucosa of rats with azoxymethane induced tumours.

Authors:  C Pizzi; S Pignata; R Calderopoli; L D'Agostino; G Tritto; G D'Adamo; G Esposito; B Daniele; G Mazzacca; A R Bianco
Journal:  Int J Exp Pathol       Date:  1994-10       Impact factor: 1.925

Review 9.  Prediction of response to drug therapy of cancer. A review of in vitro assays.

Authors:  W T Bellamy
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

10.  Variability of steroid receptors in multiple biopsies of breast cancer: effect of systemic therapy.

Authors:  Y T Lee
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.